About Us

EDP is committed to developing simple, accurate and cost-effective diagnostics that detect disease early.


EDP Biotech Corporation is a privately held diagnostics developer and Clinical Laboratory focused on the development and commercialization of immunodiagnostic tests.

EDP performs research and develops products to identify proteins present in the early stages of biological changes, to produce in vitro diagnostic tests whose primary target is early detection.

EDP’s first commercial product ColoPlex, is a new multimarker in vitro diagnostic assay to be used in the early detection of colorectal cancer.

EDP anticipates launching ColoPlex™ in 2023 in Europe.

EDP Biotech is ISO Certified


Quality Management System – ISO 13485:2016

 Company History

Meet our team of highly qualified professionals


EDP Biotech’s private investors have supported ColoPlex™ as it moves past the research and development stage towards commercialization.


EDP Biotech Corporation is looking for  qualified distributors of non-competitive IVD products for various regions internationally.